首页> 外国专利> PIPERIDINE MCH ANTAGONIST AND APPLICATION OF THE SAME TO TREATMENT OF OBESITY

PIPERIDINE MCH ANTAGONIST AND APPLICATION OF THE SAME TO TREATMENT OF OBESITY

机译:哌替啶MCH拮抗剂及其在肥胖症治疗中的应用

摘要

PPROBLEM TO BE SOLVED: To provide an antagonist to melanine-concentrating hormone (MCH). PSOLUTION: A compound expressed by structural formula (I), pharmaceutically permissible salts, esters or solvates of the same, a pharmaceutical composition containing the compound and application of the compound to treatments for eating disorders and diabetes are provided. The method for treating eating disorders and diabetes includes a process for administering an effective amount of the compound expressed by the structural formula (I) to mammals requiring the treatments for eating disorders (e.g., obesity and hyperphagia) and diabetes. Another aspect of affairs of the invention is the pharmaceutical composition for treatments for eating disorders and obesity containing the compound expressed by the structural formula (I) combined with a pharmaceutically acceptable carrier. PCOPYRIGHT: (C)2008,JPO&INPIT
机译:

要解决的问题:提供黑色素浓缩激素(MCH)的拮抗剂。

解决方案:提供了由结构式(I)表示的化合物,其药学上可接受的盐,酯或溶剂化物,包含该化合物的药物组合物以及该化合物在饮食失调和糖尿病治疗中的应用。治疗饮食失调和糖尿病的方法包括向需要治疗饮食失调(例如肥胖和食欲过剩)和糖尿病的哺乳动物施用有效量的结构式(I)表示的化合物的方法。本发明的另一方面是用于饮食失调和肥胖症治疗的药物组合物,其包含由结构式(I)表示的化合物与可药用载体。

版权:(C)2008,日本特许厅&INPIT

著录项

  • 公开/公告号JP2007284451A

    专利类型

  • 公开/公告日2007-11-01

    原文格式PDF

  • 申请/专利权人 SCHERING PLOUGH CORP;

    申请/专利号JP20070195250

  • 申请日2007-07-26

  • 分类号C07D211/34;C07D417/06;C07D401/06;C07D405/06;C07D413/06;A61P43;A61P3/04;A61P3/10;A61K31/445;A61K31/454;A61K31/4545;A61K31/4525;A61K31/4709;A61K31/517;A61K31/498;A61K31/453;

  • 国家 JP

  • 入库时间 2022-08-21 21:15:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号